Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (29)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hartung, T.K.
Right arrow Articles by Henry, J.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hartung, T.K.
Right arrow Articles by Henry, J.A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Q J Med 2002; 95: 431-437
© 2002 Association of Physicians

Hyponatraemic states following 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’) ingestion

T.K. Hartung1, E. Schofield2, A.I. Short3, M.J.A. Parr4 and J.A. Henry5,

From the 1 Respiratory Unit, Ninewells Hospital, Dundee, 2 Medical Toxicology Unit, Guy's Hospital, London, 3 Broomfield Hospital, Chelmsford, UK, 4 The Cloisters, Cherrybrook, Sydney NSW 2126, Australia, and 5 Academic Department of Accident & Emergency Medicine, Imperial College, St Mary's Hospital, London, UK

Received 2 November 2002 and in revised form 21 February 2002

Background: Life-threatening and fatal hyponatraemic complications following ecstasy use have previously been documented.

Aim: To define clinical features of hyponatraemia following the ingestion of 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’).

Design: Retrospective case series.

Methods: All enquiries to the London centre of the National Poisons Information Service (NPIS) between December 1993 and March 1996 were screened for cases of MDMA use associated with hyponatraemia (serum sodium <130 mmol/l). History of fluid consumption, presenting features and subsequent clinical course were recorded.

Results: Seventeen patients, aged 15–26 years, were identified. Serum sodium levels ranged between 107 mmol/l and 128 mmol/l. In six patients, biochemical results were consistent with inappropriate secretion of antidiuretic hormone (SIADH). Analytical confirmation of MDMA ingestion was obtained in 10 patients. Ten patients were known to have ingested a large amount of non-alcoholic or alcoholic fluid. The clinical pattern was remarkably uniform, with initial vomiting and disturbed behaviour, followed in 11 patients by seizures. Drowsiness, a mute state and disorientation were observed for up to 3 days. Two patients died; 14 made a complete recovery.

Discussion: MDMA can cause life-threatening hyponatraemic encephalopathy when accompanied by excessive fluid ingestion. The mechanism involves inappropriate secretion of antidiuretic hormone.

Address correspondence to Professor J.A. Henry, Academic Department of Accident & Emergency Medicine, Imperial College, St Mary's Hospital, London W2 1NY. e-mail: j.a.henry{at}ic.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CJASNHome page
G. A. Campbell and M. H. Rosner
The Agony of Ecstasy: MDMA (3,4-Methylenedioxymethamphetamine) and the Kidney
Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1852 - 1860.
[Abstract] [Full Text] [PDF]


Home page
JRSMHome page
A M Goudie, D S Tunstall-Pedoe, M Kerins, and J Terris
Exercise-associated hyponatraemia after a marathon: case series
J R Soc Med, July 1, 2006; 99(7): 363 - 367.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.